Live-birth evidence can tell a different story from pregnancy rankings in chronic endometritis research. https://www.mattheneus.com/editorial/pubmed-chronic-endometritis-nma-live-birth-endpoint-hierarchy-2026-10-08 #HTA #NMA #EvidenceSynthesis #HealthEconomics
#healtheconomics — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #healtheconomics, aggregated by home.social.
-
New South African modelling finds targeted PCV20 vaccination for older adults with HIV can offer a favourable balance of cost-effectiveness and budget impact.
-
When coinfections exceed chance, pooled prevalence can conceal the dependence structure that matters for evidence interpretation. #HTA #EvidenceSynthesis #HealthEconomics https://www.mattheneus.com/editorial/pubmed-malaria-schistosomiasis-coinfection-overdispersion-meta-analysis-2026-10-09
-
Thirty-three trials reveal why paediatric antiemetic networks need time-specific estimands for credible decisions. https://www.mattheneus.com/editorial/paediatric-antiemetic-nma-time-window-estimand-governance-2026-10-04 #HTA #NMA #EvidenceSynthesis #HealthEconomics
-
Phasing out low-value care takes more than identifying it: IQWiG’s evidence agenda maps how HTA can support deimplementation. https://www.mattheneus.com/editorial/iqwig-low-value-care-identification-deimplementation-evidence-agenda-2026-10-06 #HTA #EvidenceSynthesis #HealthEconomics
-
Germany’s burosumab assessment shows how evidence transfer to infants can fail when population relevance and clinical comparability remain uncertain. #HTA #HealthEconomics #RegulatoryAffairs https://www.mattheneus.com/editorial/iqwig-burosumab-infant-xlh-evidence-transfer-insufficient-2026-10-01
-
In CIDP evidence synthesis, feasibility checks on populations, outcomes and pooling should come before adjustment choices.
-
Patient choice is gaining a stronger place in German health technology assessment. The G-BA has commissioned a decision aid for planned nasal septum and turbinate surgery. https://www.mattheneus.com/editorial/g-ba-nasal-septum-turbinate-surgery-patient-decision-aid-commission-2026-10-07 #HTA #HealthEconomics #RegulatoryAffairs
-
Which sedative best balances postoperative delirium prevention against bradycardia risk? This network meta-analysis maps the trade-off.
-
A Bayesian network meta-analysis maps how lifestyle options compare for cardiometabolic outcomes in polycystic ovary syndrome. https://www.mattheneus.com/editorial/pubmed-polycystic-ovary-syndrome-lifestyle-bayesian-network-meta-analysis-2026-10-09 #HTA #NMA #EvidenceSynthesis #HealthEconomics
-
WHO has set a practical framework for monitoring how social protection can strengthen financial protection in tuberculosis care. https://www.mattheneus.com/editorial/who-tuberculosis-social-protection-monitoring-financial-protection-framework-2026-10-08 #HTA #HealthEconomics #RegulatoryAffairs
-
Which modelling choices matter most in CAR T-cell economic evaluations? A review of nine NICE appraisals identifies three areas of strongest consensus. https://www.mattheneus.com/editorial/pubmed-car-t-economic-evaluation-nine-nice-appraisals-consensus-2026-10-09 #HTA #HealthEconomics #Pharma
-
Community mental health transitions need evidence plans that connect implementation, outcomes, and local decision needs. https://www.mattheneus.com/editorial/who-community-mental-health-deinstitutionalization-guide-mixed-methods-2026-10-09 #HTA #EvidenceSynthesis #HealthEconomics
-
Crohn's disease location can reshape comparative treatment effects and the evidence questions an NMA must answer. https://www.mattheneus.com/editorial/pubmed-crohns-disease-location-treatment-efficacy-nma-2026-10-08 #HTA #NMA #EvidenceSynthesis #HealthEconomics
-
Six studies show how local costs, pathways and assumptions shape the value case for combination reliever access in asthma. https://www.mattheneus.com/editorial/asthma-ics-formoterol-cost-effectiveness-local-value-file-2026-10-08 #HTA #HealthEconomics #EvidenceSynthesis
-
When a re-evaluation changes the benefit verdict, the reimbursement case must change with it. https://www.mattheneus.com/editorial/has-zimino-levosimendan-reassessment-insufficient-clinical-benefit-2026-08-26 #HTA #HealthEconomics #RegulatoryAffairs
-
How should perioperative chemotherapy cycles be compared in gastric cancer? This network meta-analysis tests competing strategies and highlights evidence decisions for HTA teams. https://www.mattheneus.com/editorial/world-journal-gastric-cancer-perioperative-cycle-network-meta-analysis-2026-10-08 #HTA #NMA #EvidenceSynthesis #HealthEconomics
-
Seven new studies entered a living treatment network, yet its conclusions held steady. A useful case study in how surveillance can strengthen confidence in the evidence.\n\nhttps://www.mattheneus.com/editorial/pubmed-living-nma-quarterly-surveillance-stable-conclusions-2026-10-08\n\n#HTA #NMA #EvidenceSynthesis #HealthEconomics
-
What happens when a zero-event study leaves exploratory dressing comparisons unresolved? A closer look at residual differences in unanchored MAIC. https://www.mattheneus.com/editorial/sacral-dressing-unanchored-maic-residual-differences-2026-10-07 #HTA #MAIC #EvidenceSynthesis #HealthEconomics